 | • レポートコード：MRC2012A5896 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、髄膜炎菌グループBワクチンの世界市場を広く調査・分析し、今後の市場展望をまとめております。髄膜炎菌グループBワクチンの種類別市場規模（タイプ1、タイプ2）、用途別市場規模（公共、個人）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：GSK、Pfizer、 ・地域別グローバル市場分析 2015年-2020年 ・髄膜炎菌グループBワクチンの北米市場（アメリカ、カナダ、メキシコ） ・髄膜炎菌グループBワクチンのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・髄膜炎菌グループBワクチンのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・髄膜炎菌グループBワクチンの南米市場（ブラジル、アルゼンチン） ・髄膜炎菌グループBワクチンの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タイプ1、タイプ2 ・用途別分析：公共、個人 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Meningococcal Group B Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Meningococcal Group B Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Meningococcal Group B Vaccine market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Meningococcal Group B Vaccine market has been segmented into
Type 1
Type 2
By Application, Meningococcal Group B Vaccine has been segmented into:
Public
Private
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Meningococcal Group B Vaccine market presented in the report. This section sheds light on the sales growth of different regional and country-level Meningococcal Group B Vaccine markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Meningococcal Group B Vaccine market.
The report offers in-depth assessment of the growth and other aspects of the Meningococcal Group B Vaccine market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Meningococcal Group B Vaccine Market Share Analysis
Meningococcal Group B Vaccine competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Meningococcal Group B Vaccine sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Meningococcal Group B Vaccine sales, revenue and market share for each player covered in this report.
The major players covered in Meningococcal Group B Vaccine are:
GSK
Pfizer
Among other players domestic and global, Meningococcal Group B Vaccine market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Group B Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Group B Vaccine, with price, sales, revenue and global market share of Meningococcal Group B Vaccine in 2018 and 2019.
Chapter 3, the Meningococcal Group B Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Group B Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Meningococcal Group B Vaccine market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Meningococcal Group B Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Meningococcal Group B Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningococcal Group B Vaccine Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Type 1
1.2.3 Type 2
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningococcal Group B Vaccine Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public
1.3.3 Private
1.4 Overview of Global Meningococcal Group B Vaccine Market
1.4.1 Global Meningococcal Group B Vaccine Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 GSK
2.1.1 GSK Details
2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 GSK SWOT Analysis
2.1.4 GSK Product and Services
2.1.5 GSK Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Pfizer SWOT Analysis
2.2.4 Pfizer Product and Services
2.2.5 Pfizer Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Meningococcal Group B Vaccine Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Meningococcal Group B Vaccine Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Meningococcal Group B Vaccine Manufacturer Market Share in 2019
3.3.2 Top 6 Meningococcal Group B Vaccine Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Meningococcal Group B Vaccine Sales, Revenue and Market Share by Regions
4.1.1 Global Meningococcal Group B Vaccine Sales and Market Share by Regions (2015-2020)
4.1.2 Global Meningococcal Group B Vaccine Revenue and Market Share by Regions (2015-2020)
4.2 North America Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
4.3 Europe Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
4.5 South America Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Meningococcal Group B Vaccine Sales, Revenue and Market Share by Country
5.1.1 North America Meningococcal Group B Vaccine Sales and Market Share by Country (2015-2020)
5.1.2 North America Meningococcal Group B Vaccine Revenue and Market Share by Country (2015-2020)
5.2 United States Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
5.3 Canada Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
5.4 Mexico Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Meningococcal Group B Vaccine Sales, Revenue and Market Share by Country
6.1.1 Europe Meningococcal Group B Vaccine Sales and Market Share by Country (2015-2020)
6.1.2 Europe Meningococcal Group B Vaccine Revenue and Market Share by Country (2015-2020)
6.2 Germany Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
6.3 UK Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
6.4 France Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
6.5 Russia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
6.6 Italy Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Meningococcal Group B Vaccine Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Meningococcal Group B Vaccine Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Meningococcal Group B Vaccine Revenue and Market Share by Regions (2015-2020)
7.2 China Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7.3 Japan Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7.4 Korea Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7.5 India Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
7.7 Australia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Meningococcal Group B Vaccine Sales, Revenue and Market Share by Country
8.1.1 South America Meningococcal Group B Vaccine Sales and Market Share by Country (2015-2020)
8.1.2 South America Meningococcal Group B Vaccine Revenue and Market Share by Country (2015-2020)
8.2 Brazil Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
8.3 Argentina Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Meningococcal Group B Vaccine Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Meningococcal Group B Vaccine Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Meningococcal Group B Vaccine Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
9.3 Turkey Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
9.4 Egypt Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
9.5 South Africa Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Meningococcal Group B Vaccine Sales and Market Share by Type (2015-2020)
10.2 Global Meningococcal Group B Vaccine Revenue and Market Share by Type (2015-2020)
10.3 Global Meningococcal Group B Vaccine Price by Type (2015-2020)
11 Global Meningococcal Group B Vaccine Market Segment by Application
11.1 Global Meningococcal Group B Vaccine Sales Market Share by Application (2015-2020)
11.2 Global Meningococcal Group B Vaccine Revenue Market Share by Application (2015-2020)
11.3 Global Meningococcal Group B Vaccine Price by Application (2015-2020)
12 Market Forecast
12.1 Global Meningococcal Group B Vaccine Sales, Revenue and Growth Rate (2021-2025)
12.2 Meningococcal Group B Vaccine Market Forecast by Regions (2021-2025)
12.2.1 North America Meningococcal Group B Vaccine Market Forecast (2021-2025)
12.2.2 Europe Meningococcal Group B Vaccine Market Forecast (2021-2025)
12.2.3 Asia-Pacific Meningococcal Group B Vaccine Market Forecast (2021-2025)
12.2.4 South America Meningococcal Group B Vaccine Market Forecast (2021-2025)
12.2.5 Middle East & Africa Meningococcal Group B Vaccine Market Forecast (2021-2025)
12.3 Meningococcal Group B Vaccine Market Forecast by Type (2021-2025)
12.3.1 Global Meningococcal Group B Vaccine Sales Forecast by Type (2021-2025)
12.3.2 Global Meningococcal Group B Vaccine Market Share Forecast by Type (2021-2025)
12.4 Meningococcal Group B Vaccine Market Forecast by Application (2021-2025)
12.4.1 Global Meningococcal Group B Vaccine Sales Forecast by Application (2021-2025)
12.4.2 Global Meningococcal Group B Vaccine Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Meningococcal Group B Vaccine Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Meningococcal Group B Vaccine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Meningococcal Group B Vaccine Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Meningococcal Group B Vaccine Major Business
Table 9. GSK Meningococcal Group B Vaccine Total Revenue (USD Million) (2017-2018)
Table 10. GSK SWOT Analysis
Table 11. GSK Meningococcal Group B Vaccine Product and Services
Table 12. GSK Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Meningococcal Group B Vaccine Major Business
Table 15. Pfizer Meningococcal Group B Vaccine Total Revenue (USD Million) (2017-2018)
Table 16. Pfizer SWOT Analysis
Table 17. Pfizer Meningococcal Group B Vaccine Product and Services
Table 18. Pfizer Meningococcal Group B Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Global Meningococcal Group B Vaccine Sales by Manufacturer (2018-2019) (K Units)
Table 20. Global Meningococcal Group B Vaccine Revenue by Manufacturer (2018-2019) (USD Million)
Table 21. Global Meningococcal Group B Vaccine Sales by Regions (2015-2020) (K Units)
Table 22. Global Meningococcal Group B Vaccine Sales Market Share by Regions (2015-2020)
Table 23. Global Meningococcal Group B Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 24. North America Meningococcal Group B Vaccine Sales by Countries (2015-2020) (K Units)
Table 25. North America Meningococcal Group B Vaccine Sales Market Share by Countries (2015-2020)
Table 26. North America Meningococcal Group B Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 27. North America Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020)
Table 28. Europe Meningococcal Group B Vaccine Sales by Countries (2015-2020) (K Units)
Table 29. Europe Meningococcal Group B Vaccine Sales Market Share by Countries (2015-2020)
Table 30. Europe Meningococcal Group B Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 31. Asia-Pacific Meningococcal Group B Vaccine Sales by Regions (2015-2020) (K Units)
Table 32. Asia-Pacific Meningococcal Group B Vaccine Sales Market Share by Regions (2015-2020)
Table 33. Asia-Pacific Meningococcal Group B Vaccine Revenue by Regions (2015-2020) (USD Million)
Table 34. South America Meningococcal Group B Vaccine Sales by Countries (2015-2020) (K Units)
Table 35. South America Meningococcal Group B Vaccine Sales Market Share by Countries (2015-2020)
Table 36. South America Meningococcal Group B Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 37. South America Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020)
Table 38. Middle East & Africa Meningococcal Group B Vaccine Sales by Countries (2015-2020) (K Units)
Table 39. Middle East & Africa Meningococcal Group B Vaccine Sales Market Share by Countries (2015-2020)
Table 40. Middle East & Africa Meningococcal Group B Vaccine Revenue by Countries (2015-2020) (USD Million)
Table 41. Middle East & Africa Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020)
Table 42. Global Meningococcal Group B Vaccine Sales by Type (2015-2020) (K Units)
Table 43. Global Meningococcal Group B Vaccine Sales Share by Type (2015-2020)
Table 44. Global Meningococcal Group B Vaccine Revenue by Type (2015-2020) (USD Million)
Table 45. Global Meningococcal Group B Vaccine Revenue Share by Type (2015-2020)
Table 46. Global Meningococcal Group B Vaccine Sales by Application (2015-2020) (K Units)
Table 47. Global Meningococcal Group B Vaccine Sales Share by Application (2015-2020)
Table 48. Global Meningococcal Group B Vaccine Sales Forecast by Regions (2021-2025) (K Units)
Table 49. Global Meningococcal Group B Vaccine Market Share Forecast by Regions (2021-2025)
Table 50. Global Meningococcal Group B Vaccine Sales Forecast by Type (2021-2025) (K Units)
Table 51. Global Meningococcal Group B Vaccine Market Share Forecast by Type (2021-2025)
Table 52. Global Meningococcal Group B Vaccine Sales Forecast by Application (2021-2025)
Table 53. Global Meningococcal Group B Vaccine Market Share Forecast by Application (2021-2025)
Table 54. Direct Channel Pros & Cons
Table 55. Indirect Channel Pros & Cons
Table 56. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Meningococcal Group B Vaccine Picture
Figure 2. Global Sales Market Share of Meningococcal Group B Vaccine by Type in 2019
Figure 3. Type 1 Picture
Figure 4. Type 2 Picture
Figure 5. Meningococcal Group B Vaccine Sales Market Share by Application in 2018
Figure 6. Public Picture
Figure 7. Private Picture
Figure 8. Global Meningococcal Group B Vaccine Market Status and Outlook (2015-2025) (USD Million)
Figure 9. United States Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 10. Canada Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Mexico Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Germany Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 13. France Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 14. UK Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Russia Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Italy Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 17. China Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Japan Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Korea Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 20. India Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Southeast Asia Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Australia Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 23. Brazil Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Egypt Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Saudi Arabia Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 26. South Africa Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Turkey Meningococcal Group B Vaccine Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Global Meningococcal Group B Vaccine Sales Market Share by Manufacturer in 2019
Figure 29. Global Meningococcal Group B Vaccine Revenue Market Share by Manufacturer in 2019
Figure 30. Top 3 Meningococcal Group B Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 31. Top 6 Meningococcal Group B Vaccine Manufacturer (Revenue) Market Share in 2019
Figure 32. Key Manufacturer Market Share Trend
Figure 33. Global Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 34. Global Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 35. Global Meningococcal Group B Vaccine Revenue Market Share by Regions (2015-2020)
Figure 36. Global Meningococcal Group B Vaccine Revenue Market Share by Regions in 2018
Figure 37. North America Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
Figure 38. Europe Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
Figure 40. South America Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
Figure 41. Middle East & Africa Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020)
Figure 42. North America Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 43. North America Meningococcal Group B Vaccine Sales Market Share by Countries (2015-2020)
Figure 44. North America Meningococcal Group B Vaccine Sales Market Share by Countries in 2018
Figure 45. North America Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 46. North America Meningococcal Group B Vaccine Revenue Market Share by Countries in 2018
Figure 47. United States Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 48. Canada Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Mexico Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Europe Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 51. Europe Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020)
Figure 52. Europe Meningococcal Group B Vaccine Revenue Market Share by Countries in 2019
Figure 53. Germany Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 54. UK Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 55. France Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 56. Russia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Italy Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Asia-Pacific Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 59. Asia-Pacific Meningococcal Group B Vaccine Sales Market Share by Regions 2019
Figure 60. Asia-Pacific Meningococcal Group B Vaccine Revenue Market Share by Regions 2019
Figure 61. China Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Japan Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Korea Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 64. India Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Southeast Asia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 66. South America Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 67. South America Meningococcal Group B Vaccine Sales Market Share by Countries in 2019
Figure 68. South America Meningococcal Group B Vaccine Revenue Market Share by Countries in 2019
Figure 69. Brazil Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Middle East and Africa Meningococcal Group B Vaccine Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. Middle East and Africa Meningococcal Group B Vaccine Sales Market Share by Countries in 2019
Figure 73. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Countries (2015-2020)
Figure 74. Middle East and Africa Meningococcal Group B Vaccine Revenue Market Share by Countries in 2019
Figure 75. Saudi Arabia Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 76. Egypt Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Turkey Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 78. South Africa Meningococcal Group B Vaccine Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Global Meningococcal Group B Vaccine Sales and Growth Rate (2021-2025) (K Units)
Figure 80. Global Meningococcal Group B Vaccine Revenue and Growth Rate (2021-2025) (USD Million)
Figure 81. North America Sales Meningococcal Group B Vaccine Market Forecast (2021-2025) (K Units)
Figure 82. Europe Sales Meningococcal Group B Vaccine Market Forecast (2021-2025) (K Units)
Figure 83. Asia-Pacific Sales Meningococcal Group B Vaccine Market Forecast (2021-2025) (K Units)
Figure 84. South America Sales Meningococcal Group B Vaccine Market Forecast (2021-2025) (K Units)
Figure 85. Middle East & Africa Sales Meningococcal Group B Vaccine Market Forecast (2021-2025) (K Units)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel
髄膜炎菌コンジュゲートの世界市場（～2026年） Meningococcal disease can become life threatening quickly, and teens are at higher risk of getting it. It's a leading cause of bacterial meningitis in teens. Meningitis is a dangerous inflammation of the lining of the brain and spinal cord. Two meningitis vaccines protects against four types of meni…- 髄膜炎菌ワクチンの世界市場（～2026年） Market Analysis and Insights: Global Meningococcal Vaccines Market The global Meningococcal Vaccines market size is projected to reach US$ 250.5 million by 2026, from US$ 239 million in 2020, at a CAGR of 4.4%% during 2021-2026. Global Meningococcal Vaccines Scope and Market Size Meningococcal Vacci…
- 結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 帯状疱疹ワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Zoster Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Zoster Vaccine market report p…
- アデノウイルスワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Adenovirus Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Adenovirus Vaccine market …